Previous 10 | Next 10 |
Dr. Reddy’s Laboratories (NYSE:RDY) announces the re-launch of over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Bayer HealthCare's Aleve, in U.S. market. Dr. Reddy’s Naproxen Sodium Tablets is an OTC nonsteroidal anti-inflammatory drug fo...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the re-launch of over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-br...
Image source: The Motley Fool. DrReddy's Laboratories Ltd (NYSE: RDY) Q1 2022 Earnings Call Jul 29, 2021 , 8:00 p.m. ET Operator Continue reading For further details see: DrReddy's Laboratories Ltd (RDY) Q1 2022 Earnings Call Transcript ...
Dr. Reddy's Laboratories Limited (RDY) Q1 2021 Earnings Conference Call July 27, 2021 08:00 AM ET Company Participants Amit Agarwal - Head, Investor Relations & Director, Finance, FP&A & Investor Relations Erez Israeli - Chief Executive Officer Parag Agarwal - Chief Financial Offi...
Marcos Brindicci/Getty Images News Dr. Reddy's Laboratories ([[RDY]] -12.5%) ADRs are on track to record the biggest one-day loss since July 2016 after the company failed to meet the expectations with its Q1 results for fiscal 2021. In reaction, Credit Suisse has downgraded the stock to ...
The CPI-W increased 6.1% year-over-year in June. Healthcare is historically a strong performer later in the business cycle. The healthcare sector is improving in our large cap sector ranking. Top scoring healthcare stocks worth adding to your watch list. For further deta...
Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that its Annual Report on Form 20-F containing its consolidated financial statements f...
Fortress Biotech ([[FBIO]] +0.8%) partner company Journey Medical announces an agreement with Dr. Reddy’s Laboratories ([[RDY]] -0.1%) for the collaborative development and commercialization of the DFD-29 program (Minocycline Modified Release Capsules 40 mg) for the treatment of rosace...
NEW YORK and SCOTTSDALE, Ariz., June 30, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”), a partner company of Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), today announced an agreement with Dr. Reddy’s Laboratories Ltd. (...
Sundry Photography/iStock Editorial via Getty Images Several pharmaceutical companies in India have joined hands with Merck ([[MRK]] +0.2%) for a local clinical trial for the company’s experimental COVID-19 therapy molnupiravir, Reuters reports. The clinical trial is expected...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Dr. Reddy's Laboratories Ltd Website:
2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with pro...